Gilead Sciences (NASDAQ: GILD) | Will Sales Fall After Warning?

Gilead Sciences Inc. (NASDAQ: GILD) When it comes to the world of medicine, Gilead Sciences is a major player. As a matter of fact, the company currently leads the world in both HIV and hepatitis C treatments. However, they did take a decent hit in the stock market Monday after sending a warning to doctors … Read more